NRI

PARMAX PHARMA SHARE PRICE

Sector Pharmaceuticals
BSE 540359
45.00
0.00 (0.00 %)
Buy
B
Sell
S
BSE

Overview

Day Low

43.99

Day High

47.50

52 Week Low

25.03

52 Week High

54.00

All Time Low

12.50

All Time High

81.90

Open

45.22

Close

45.00

Volume

1,235

Mkt cap (Cr)

16.83

P/E ratio

0.00

P/B ratio

-0.05%

Div yield

0.00%

6M return

2.86%

1Y return

55.07%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

45.00 0.00%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Parmax Pharma Ltd

Stock PE (TTM)

0

Promoter Holding

30.8%

Book Value

-2.1628

ROCE

0%

ROE

0%

Incorporated in Nov.`94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax`s pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May`97.

Parmax Pharma share price as on 23 Apr 2025 is Rs. 45. Over the past 6 months, the Parmax Pharma share price has increased by 2.86% and in the last one year, it has increased by 55.07%. The 52-week low for Parmax Pharma share price was Rs. 25.03 and 52-week high was Rs. 54.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

540359

INE240T01014

Sep

Parmax Pharma Ltd FAQs

You can buy Parmax Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Parmax Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 23, 2025 04:00 PM the closing price of Parmax Pharma Ltd was Rs.45.00.

The latest PE ratio of Parmax Pharma Ltd as of Apr 23, 2025 04:00 PM is 0.00

The latest PB ratio of Parmax Pharma Ltd as of Apr 23, 2025 04:00 PM is -0.05

The 52-week high of Parmax Pharma Ltd share price is Rs. 54.00 while the 52-week low is Rs. 25.03

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Apr 23, 2025 04:00 PM, the market cap of Parmax Pharma Ltd stood at Rs. 16.83 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.